Target Name: WAC-AS1
NCBI ID: G220906
Review Report on WAC-AS1 Target / Biomarker Content of Review Report on WAC-AS1 Target / Biomarker
WAC-AS1
Other Name(s): WAC antisense RNA 1 (head to head)

WAC-AS1: A Non-Coding RNA Molecule as A Potential Drug Target Or Biomarker

WAC-AS1 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is derived from the Wnt-associated gene AS1 and has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. The discovery of WAC-AS1 as a potential drug target has significant implications for the development of new treatments for various diseases.

The Wnt signaling pathway is a well-established mechanism of cell-mediated signaling that is involved in many important cellular processes, including development, growth, and differentiation. Wnt signaling involves the formation of the Wnt protein, which is a transmembrane glycoprotein that is involved in the development of the neural tube during embryonic development. In addition to its role in embryonic development, Wnt has also been shown to play a role in adult tissue repair and regeneration.

WAC-AS1 is a non-coding RNA molecule that is derived from the Wnt-associated gene AS1. It is characterized by the presence of a specific stem-loop region, which is a common feature of many RNA molecules that are derived from genomic RNA. The stem-loop region is responsible for the stability and translation of the molecule into a functional RNA molecule.

WAC-AS1 has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. For example, studies have shown that WAC-AS1 is involved in the regulation of cell adhesion, as well as the migration and invasion of cancer cells. In addition, WAC-AS1 has also been shown to play a role in the regulation of stem cell proliferation and the process of cell differentiate.

WAC-AS1 is also considered as a potential biomarker for some diseases, such as cancer, where it has been shown to be expressed at different stages of the disease progression. This suggests that it may be a useful diagnostic or therapeutic target for cancer treatment.

In addition, some studies have also shown that WAC-AS1 may have a role in the regulation of cellular processes that are important for overall health and well-being, such as inflammation and stress response.

The potential drug target status of WAC-AS1 is also under investigation. Studies have shown that inhibiting WAC-AS1 can lead to the inhibition of various cellular processes that are important for the growth, survival, and progression of cancer cells. This suggests that WAC-AS1 may be a potential drug target for cancer treatment.

Conclusion

In conclusion, WAC-AS1 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its role in various cellular processes, including cell adhesion, migration, and invasion, as well as its potential as a biomarker for cancer, make it an important target for further research. Further studies are needed to fully understand the role of WAC-AS1 in cellular processes and its potential as a drug target.

Protein Name: WAC Antisense RNA 1 (head To Head)

The "WAC-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WAC-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

WAKMAR1 | WAKMAR2 | WAPL | WARS1 | WARS2 | WARS2-AS1 | WAS | WASF1 | WASF2 | WASF3 | WASF4P | WASF5P | WASH complex | WASH2P | WASH3P | WASH4P | WASH5P | WASH6P | WASH7P | WASH8P | WASHC1 | WASHC2A | WASHC2C | WASHC3 | WASHC4 | WASHC5 | WASIR1 | WASL | WAVE1 complex | WBP1 | WBP11 | WBP11P1 | WBP1L | WBP2 | WBP2NL | WBP4 | WDCP | WDFY1 | WDFY2 | WDFY3 | WDFY3-AS2 | WDFY4 | WDHD1 | WDPCP | WDR1 | WDR11 | WDR11-DT | WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87